Modalis Therapeutics Corporation
Notice of Monthly Exercise Status for the 19th Stock Acquisition Rights Issued under Third-Party Allocation (with Exercise Price Adjustment Provisions)
Public disclosure of the August exercise status for stock options (19th issue with exercise price adjustment provisions). For the target month, 2,090,000 shares were issued, 20,900 options were exercised, accounting for 8.7% of the total issued shares. Unexercised options at month-end were 138,700, and the exercise restriction ratio was 2.2%.
Key Figures
- Issued shares: 2,090,000 shares
- Number of stock options exercised: 20,900 shares
- Total issued shares: 240,000 shares
- Unexercised stock options (month-end): 138,700 shares
- Exercise ratio: 2.2%
AI要約
Section Heading
This is a monthly exercise status notice for the 19th issue of stock acquisition rights issued to third parties. For the target month, 2,090,000 shares were issued, 20,900 stock options were actually exercised, representing 8.7% of the issued total. Unexercised rights at the end of the previous month were 159,600, and at month-end were 138,700, with an exercise ratio of 2.2% out of nine levels of compliance with exercise restrictions. This references the previously disclosed notice (as of May 27, 2026).
Section 2 Heading
The monthly trend shows a reduction in unexercised rights, while an 8.7% exercise rate is observed, and exercise restrictions in accordance with the regulations continue to be observed. The status of issued shares and treasury shares, and future exercise trends, may influence the market. For details, please refer to the May 27 notice, and if there are additional disclosures, they will be announced as appropriate.
Modalis Therapeutics Corporation
Company overview · Stock price · Financial data · All IR
